The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Dent Assoc, Vol 136, No 9, 1282-1285.
© 2005 American Dental Association

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MANDEL, L.
Right arrow Articles by CHALOM, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MANDEL, L.
Right arrow Articles by CHALOM, E. C.
Related Collections
Right arrow Infection Control

CLINICAL PRACTICE

CASE REPORT

Treatment of refractory sarcoidal parotid gland swelling in a previously reported unresponsive case



LOUIS MANDEL, D.D.S., BARRY WOLINSKY, D.D.S. and ELIZABETH C. CHALOM, M.D.

Background. Sarcoidosis is a multi-system granulomatous disease that is seen occasionally in patients with characteristic bilateral parotid gland swelling. Conventional therapy has involved either no treatment because of spontaneous remission or corticosteroids when organ involvement is severe.

Case Description. The authors describe a previously published case report of a patient with sarcoidosis with parotid gland swellings who did not respond to standard therapy. Despite the use of various immunosuppressive agents, the swellings failed to resolve over a three-year period. It was only after a newly recommended agent, infliximab, was used that the patient’s condition was treated successfully.

Clinical Implications. It is important for dental practitioners to be familiar with manifestations of sarcoidosis, particularly its salivary gland aspects. Inherent in the knowledge of the disease is the therapeutic approach to both routine and recalcitrant cases.

Key Words: Parotid; sarcoidosis; infliximab







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright©1995-2005 American Dental Association (ADA).
Reproduction or republication strictly prohibited without prior written permission of ADA.